Makani Science
Makani Science, based in Irvine, California, specializes in developing innovative medical devices, including the world's first wireless patch for respiratory monitoring, targeting a market potential of close to $100 billion.
Services
Makani Science specializes in creating innovative medical devices aimed at monitoring respiratory health. The company's primary service revolves around their proprietary wireless patch, designed for continuous and accurate breathing monitoring. This device caters to a variety of patient needs, from those undergoing sedation for medical procedures to individuals needing regular respiratory monitoring at home. The technology integrates Bluetooth connectivity to ensure a decluttered patient environment and facilitate easy data collection for long-term health management.
Founders
Makani Science was founded by a core team operating out of Irvine, California. The team is small, consisting of only two members, but their cutting-edge work in medical device innovation has quickly garnered attention and support within the healthcare industry. While specific names of the founders are not provided, their involvement in high-profile accelerators and recognitions signal a dedicated effort towards transforming respiratory health monitoring.
Products
The flagship product of Makani Science is a postage-sized, stretchable sensor that provides continuous, wireless respiratory monitoring. Designed for both clinical and home environments, the sensor promises comfort and accuracy, leveraging Bluetooth technology. This device addresses a significant need in healthcare by improving the safety and quality of sedation monitoring. Future plans include using the patch to collect a large database of respiratory patterns to help in disease management through machine learning algorithms.
Accelerator Participation
Makani Science has participated in several prestigious accelerator programs, which have facilitated its growth and development. These include Y-Combinator (Summer 2021), Medtech Innovator, UC Launch, and the FDA-funded Consortium for Technology & Innovation in Pediatrics. Such programs have provided Makani Science with vital resources, mentorship, and networking opportunities, significantly contributing to its reputation as a promising medtech startup.
Market Opportunities
Makani Science has identified substantial market opportunities for its wireless respiratory monitoring technology. The initial target market includes patients undergoing sedation for medical procedures, with a focus on enhancing safety and monitoring efficiency. Looking ahead, the company sees extensive applications in pediatrics, disease management, and wellness/performance measurement. The total potential market for these targeted areas could reach approximately $100 billion by 2023, indicating significant growth prospects for the company.
